IM Cannabis (IMCC) Asset Utilization Ratio (2021 - 2026)
IM Cannabis (IMCC) posted quarterly Asset Utilization Ratio of 1.84 for Q1 2026, up 39.14% year-over-year from 1.32 in Q1 2025, and up 28.94% quarter-over-quarter from 1.43 in Q4 2025.
IM Cannabis (IMCC) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
IM Cannabis' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 1.84 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 39.14% year-over-year to 1.84; the TTM figure through Mar 2026 stood at 1.84 (up 39.14% YoY), while the FY2025 annual figure was 1.53, up 25.43% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 1.84, up from 1.43 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.84 in Q1 2026, with the low at 0.18 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 1.08 (2024), against an average of 1.0.
- The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio retreated 17.04% in 2022, then soared 410.6% in 2023.
- IM Cannabis' Asset Utilization Ratio stood at 0.55 in 2022, then soared by 74.24% to 0.97 in 2023, then surged by 34.43% to 1.3 in 2024, then increased by 9.79% to 1.43 in 2025, then increased by 28.94% to 1.84 in 2026.
- Business Quant data shows IMCC's Asset Utilization Ratio at 1.84 in Q1 2026, 1.43 in Q4 2025, and 1.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | 1.89 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 |
| Mar 31, 2026 | 1.84 |
| Dec 31, 2025 | 1.43 |
| Sep 30, 2025 | 1.21 |
| Jun 30, 2025 | 1.23 |
| Mar 31, 2025 | 1.32 |
| Dec 31, 2024 | 1.30 |
| Sep 30, 2024 | 1.22 |
| Jun 30, 2024 | 1.23 |
| Mar 31, 2024 | 1.08 |
| Dec 31, 2023 | 0.97 |
| Sep 30, 2023 | 0.97 |
| Jun 30, 2023 | 0.97 |
| Mar 31, 2023 | 0.94 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 0.32 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.18 |
| Jun 30, 2021 | 0.16 |
| Mar 31, 2021 | 0.22 |